| Literature DB >> 35952672 |
Liang Li1, Fang Fang2, Xue Feng1, Pei Zhuang1, Haoliang Huang1, Pingting Liu1, Liang Liu1, Adam Z Xu3, Lei S Qi4, Le Cong5, Yang Hu6.
Abstract
Axon regeneration holds great promise for neural repair of CNS axonopathies, including glaucoma. Pten deletion in retinal ganglion cells (RGCs) promotes potent optic nerve regeneration, but only a small population of Pten-null RGCs are actually regenerating RGCs (regRGCs); most surviving RGCs (surRGCs) remain non-regenerative. Here, we developed a strategy to specifically label and purify regRGCs and surRGCs, respectively, from the same Pten-deletion mice after optic nerve crush, in which they differ only in their regeneration capability. Smart-Seq2 single-cell transcriptome analysis revealed novel regeneration-associated genes that significantly promote axon regeneration. The most potent of these, Anxa2, acts synergistically with its ligand tPA in Pten-deletion-induced axon regeneration. Anxa2, its downstream effector ILK, and Mpp1 dramatically protect RGC somata and axons and preserve visual function in a clinically relevant model of glaucoma, demonstrating the exciting potential of this innovative strategy to identify novel effective neural repair candidates.Entities:
Keywords: Anxa2; ILK; Mpp1; Pten; RGC; Smart-Seq2; axon regeneration; glaucoma; neural repair; optic nerve
Mesh:
Year: 2022 PMID: 35952672 PMCID: PMC9391304 DOI: 10.1016/j.neuron.2022.06.022
Source DB: PubMed Journal: Neuron ISSN: 0896-6273 Impact factor: 18.688